Daiwa Securities Group Inc. Cuts Holdings in TESARO Inc (TSRO)

Daiwa Securities Group Inc. cut its holdings in shares of TESARO Inc (NASDAQ:TSRO) by 36.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,151 shares of the biopharmaceutical company’s stock after selling 8,058 shares during the period. Daiwa Securities Group Inc.’s holdings in TESARO were worth $1,173,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. State Street Corp increased its stake in shares of TESARO by 17.9% in the 2nd quarter. State Street Corp now owns 1,168,913 shares of the biopharmaceutical company’s stock valued at $163,496,000 after acquiring an additional 177,057 shares during the last quarter. Janus Henderson Group PLC increased its stake in shares of TESARO by 24.9% in the 3rd quarter. Janus Henderson Group PLC now owns 895,556 shares of the biopharmaceutical company’s stock valued at $115,616,000 after acquiring an additional 178,406 shares during the last quarter. Pictet Asset Management Ltd. increased its stake in shares of TESARO by 58.1% in the 3rd quarter. Pictet Asset Management Ltd. now owns 630,904 shares of the biopharmaceutical company’s stock valued at $81,450,000 after acquiring an additional 231,799 shares during the last quarter. Alyeska Investment Group L.P. increased its stake in shares of TESARO by 37.4% in the 3rd quarter. Alyeska Investment Group L.P. now owns 407,505 shares of the biopharmaceutical company’s stock valued at $52,609,000 after acquiring an additional 110,820 shares during the last quarter. Finally, Perceptive Advisors LLC increased its stake in shares of TESARO by 8.1% in the 3rd quarter. Perceptive Advisors LLC now owns 388,651 shares of the biopharmaceutical company’s stock valued at $50,175,000 after acquiring an additional 29,100 shares during the last quarter.

In related news, SVP Martin H. Jr. Huber sold 829 shares of the stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $85.24, for a total transaction of $70,663.96. Following the completion of the sale, the senior vice president now directly owns 8,101 shares of the company’s stock, valued at approximately $690,529.24. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 40.50% of the stock is currently owned by corporate insiders.

Shares of TESARO Inc (NASDAQ:TSRO) opened at $60.00 on Friday. TESARO Inc has a 52 week low of $55.02 and a 52 week high of $192.94. The company has a debt-to-equity ratio of 0.34, a quick ratio of 4.35 and a current ratio of 4.73. The stock has a market capitalization of $3,260.00, a P/E ratio of -7.12 and a beta of 1.25.

A number of analysts have recently commented on the company. BidaskClub cut TESARO from a “sell” rating to a “strong sell” rating in a research note on Saturday, February 10th. Piper Jaffray Companies reaffirmed a “hold” rating and issued a $65.00 price target on shares of TESARO in a research note on Thursday, January 18th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $150.00 price target (down from $190.00) on shares of TESARO in a research note on Thursday, January 18th. Morgan Stanley lowered their price target on TESARO from $165.00 to $156.00 and set an “overweight” rating for the company in a research note on Tuesday, January 16th. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $158.00 price target on shares of TESARO in a research note on Friday, January 12th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $149.97.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.thelincolnianonline.com/2018/02/17/daiwa-securities-group-inc-cuts-holdings-in-tesaro-inc-tsro.html.

About TESARO

TESARO, Inc is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.

Want to see what other hedge funds are holding TSRO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TESARO Inc (NASDAQ:TSRO).

Institutional Ownership by Quarter for TESARO (NASDAQ:TSRO)

Receive News & Ratings for TESARO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TESARO and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply